Acute obstructive cholangiopathy in interleukin-6 deficient mice: Compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction

Liver

Volumn 20, Issue 2, 2000, Pages 114-124

  Liu, Zejin ^a   Sakamoto, Toshiki ^a   Yokomuro, Shigeki ^a   Ezure, Tsukasa ^a   Subbotin, Vladimir ^a   Murase, Noriko ^a   Contrucci, Sarah ^a   Demetris, Anthony J ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Ductular reaction; Growth factors; Interleukin 6; Knock out; Obstructive cholangiopathy

Indexed keywords

DNA; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILE DUCT OBSTRUCTION; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SYNTHESIS; EPITHELIUM CELL; GENE EXPRESSION; HISTOLOGY; INFLAMMATORY CELL; LIVER CELL; LIVER INJURY; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; SIGNAL TRANSDUCTION; STELLATE CELL;

ACUTE DISEASE; ALANINE TRANSAMINASE; ANIMALS; BILE DUCTS, INTRAHEPATIC; BILIRUBIN; CELLS, CULTURED; CHOLESTASIS, EXTRAHEPATIC; DNA; DNA PRIMERS; DNA REPLICATION; EPITHELIAL CELLS; GROWTH INHIBITORS; HEPATOCYTE GROWTH FACTOR; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LIVER; LYMPHOKINES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHOLINES; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 0034048319     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2000.020002114.x     Document Type: Article

References (26)

1. MATSUMOTO K, FUJII H, MICHALOPOULOS G, FUNG J J, DEMETRIS A J. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology 1994; 20: 376-82.
2. PATEL T, LARUSSO N F, GORES G J. Interleukin-6 suppresses cholangiocyte apoptosis by down-regulation of Bax. Hepatology 1997; 26: 226A.
3. YASOSHIMA M, KONO N, SUGAWARA H, KATAYANAGI K, HARADA K, NAKANUMA Y. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. Lab Invest 1998; 78: 89-100.
4. YOKOMURO S, LUNZ J G, SAKAMOTO T, EZURE T, MURASE N, DEMETRIS A J. The Effect of Interleukin-6 (IL-6)/gp130 signaling on biliary epithelial cell growth, in vitro. Cytokine 2000 (in press).
5. PARK J, GORES G J, PATEL T. Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase [In process citation]. Hepatology 1999; 29: 1037-43.
6. OKADA K, SHIMIZU Y, NAMBE S, KIGUCHI K, WATANABE A. Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line. J Gastroenterol Hepatol 1994; 9: 462-7.
7. YOKOMURO S, TSUJI H, LUNZ J, SAKAMOTO T, EZURE T, MURASE N, DEMETRIS A J. Growth control of human biliary epithelial cell growth by IL-6. HGF, TGFb1 and activin A: a comparison of cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells (submitted).
8. LIU Y, MICHALOPOULOS G K, ZARNEGAR R. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J Biol Chem 1994; 269: 4152-60.
9. LIU Z, SAKAMOTO T, EZURE T, et al. IL-6, HGF and their receptors in biliary epithelial cells during a type I ductular reaction: Interactions between the periductal inflammatory and stromal cells and the biliary epithelium. Hepatology 1998; 28: 1260-8.
10. OMORI N, EVARTS R P, OMORI M, HU Z, MARSDEN E R, THORGEIRSSON S S. Expression of leukemia inhibitory factor and its receptor during liver regeneration in the adult rat. Lab Invest 1996; 75: 15-24.
11. BEMELMANS M H, GOUMA D J, GREVE J W, BUURMAN W A. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 1992; 15: 1132-6.
12. GOYDOS J S, BRUMFIELD A M, FREZZA E, BOOTH A, LOTZE M T, CARTY S E. Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker [In process citation]. Ann Surg 1998; 227: 398-404.
13. POLI V, BALENA R, FATTORI E, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994; 13: 1189-96.
14. CRESSMAN D E, GREENBAUM L E, DEANGELIS R A, et al.Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379-83.
15. YANG L, FARIS R A, HIXSON D C. Long-term culture and characteristics of normal rat liver bile duct epithelial cells. Gastroenterology 1993; 104: 840-52.
16. BENIGNI F, FANTUZZI G, SACCO S, et al. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood 1996; 87: 1851-4.
17. SHIBAYAMA Y. Factors producing bile infarction and bile duct proliferation in biliary obstruction. J Pathol 1990; 160: 57-62.
18. EZURE T, SAKAMOTO T, LIU Z, YOKOMURO S, MURASE N, DEMETRIS, A J. Interleukin-6 and uncompensated cirrhosis. Hepatology 1998; 28: 525A.
19. HEINRICH P C, BEHRMANN I G, SCHAPER F, GRAEVE L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway1. Biochem J 1998; 334: 297-314.
20. Gu Z J, WIJDENES J, ZHANG X G, HALLET M M, CLEMENT C, KLEIN B. Anti-gp130 transducer monoclonal antibodies specifically inhibiting ciliary neurottophic factor, interleukin-6, interleukin-11, leukemia inhibitory factor or oncostatin M. J Immunol Methods 1996; 190: 21-7.
21. WIJDENES J, HEINRICH P C. MULLER-NEWEN G, et al. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. Eur J Immunol 1995; 25: 3474-81.
22. SONNE O, DAVIDSEN O, MOLLER B K, MUNCK PETERSEN C. Cellular targets and receptors for interleukin-6. I. In vivo and in vitro uptake of IL-6 in liver and hepatocytes. Eur J Clin Invest 1990; 20: 366-76.
23. HIROTA H, CHEN J, BETZ U A, et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 1999; 97: 189-98.
24. PAN J, FUKUDA K, SAITO M, et al. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 1999; 84: 1127-36.
25. EZURE T, SAKAMOTO T, LUNZ J G, TSUJI H, et al. The development and compensation of biliary cirrhosis in interleukin-6 deficient mice. Am J Pathol 1999 (submitted).
26. MOGHUL A, LIN L, BEEDLE A, et al. Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene 1994; 9: 2045-52.